QIA: Supira Medical Secures $120 M in Oversubscribed Series E Financing to Advance pVAD Market

The newly secured funds will be directed toward expanding Supira's clinical programmes focussed on high-risk percutaneous coronary intervention (HRPCI) and cardiogenic shock (CS) Supira Medical has completed an oversubscribed Series E financing round, raising $120 million to accelerate its mission of transforming the percutaneous ventricular assist device (pVAD) market. The funding round was led by [...]